Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,140 INR | +0.29% | +2.94% | +2.70% |
Feb. 02 | Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Jan. 31 | Transcript : Ajanta Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024 |
Sales 2024 * | 42.01B 504M | Sales 2025 * | 47.09B 566M | Capitalization | 269B 3.23B |
---|---|---|---|---|---|
Net income 2024 * | 8.08B 97.02M | Net income 2025 * | 9.5B 114M | EV / Sales 2024 * | 6.21 x |
Net cash position 2024 * | 7.97B 95.72M | Net cash position 2025 * | 13.8B 166M | EV / Sales 2025 * | 5.41 x |
P/E ratio 2024 * |
33.6
x | P/E ratio 2025 * |
28.4
x | Employees | 7,713 |
Yield 2024 * |
0.95% | Yield 2025 * |
0.78% | Free-Float | 50.31% |
Latest transcript on Ajanta Pharma Limited
1 day | +0.29% | ||
1 week | +2.94% | ||
Current month | -4.07% | ||
1 month | -3.74% | ||
3 months | -2.06% | ||
6 months | +24.52% | ||
Current year | +2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 98-12-31 | |
Chief Executive Officer | 52 | 95-12-31 | |
Director of Finance/CFO | 59 | 98-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 95-12-31 | |
Chairman | 77 | 79-12-30 | |
Director/Board Member | 78 | 08-10-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +0.68% | - | |
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2,140 | +0.29% | 35 470 |
24-04-24 | 2,134 | +0.16% | 69,788 |
24-04-23 | 2,130 | +1.86% | 98,235 |
24-04-22 | 2,091 | +0.29% | 138,405 |
24-04-19 | 2,085 | +0.32% | 34,465 |
Delayed Quote NSE India S.E., April 25, 2024 at 06:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.70% | 3.22B | |
+20.70% | 42.78B | |
+18.59% | 22.25B | |
+14.30% | 14.39B | |
+12.83% | 13.55B | |
+38.02% | 11.27B | |
-9.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 5.01B |
- Stock Market
- Equities
- AJANTPHARM Stock